The Effect of Body Mass Index on Survival in Advanced Epithelial Ovarian Cancer
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Bae, Hyo Sook | - |
dc.contributor.author | Hong, Jin Hwa | - |
dc.contributor.author | Ki, Kyoung-Do | - |
dc.contributor.author | Song, Jae Yun | - |
dc.contributor.author | Shin, Jin Woo | - |
dc.contributor.author | Lee, Jong Min | - |
dc.contributor.author | Lee, Jae Kwan | - |
dc.contributor.author | Lee, Nak Woo | - |
dc.contributor.author | Lee, Chan | - |
dc.contributor.author | Lee, Kyu Wan | - |
dc.contributor.author | Kim, Yong Min | - |
dc.date.available | 2020-02-28T17:42:00Z | - |
dc.date.created | 2020-02-06 | - |
dc.date.issued | 2014-06 | - |
dc.identifier.issn | 1011-8934 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/12557 | - |
dc.description.abstract | Controversy remains regarding the effect of obesity on the survival of patients with ovarian cancer in Asia. This study examined the impact of obesity on the survival outcomes in advanced epithelial ovarian cancer (EOC) using Asian body mass index (BMI) criteria. The medical records of patients undergoing surgery for advanced (stage III and IV) EOC were reviewed. Statistical analyses included ANOVA, chi-square test, Kaplan-Meier survival and Cox regression analysis. Among all 236 patients, there were no differences in overall survival according to BMI except in underweight patients. In a multivariate Cox analysis, surgical optimality and underweight status were independent and significant prognostic factors for survival (HR, 2.302; 95% CI, 1.326-3.995; P = 0.003 and HR, 8.622; 95% CI, 1.871-39.737; P = 0.006, respectively). In the subgroup of serous histology and optimal surgery, overweight and obese I patients showed better survival than normal weight patients (P = 0.012). We found that underweight BMI and surgical optimality are independent risk factors for the survival of patients with advanced ovarian cancer. High BMI groups (overweight, obese I and II) are not associated with the survival of advanced EOC patient. However, in the subgroup of EOC patients with serous histology and after optimal operation, overweight and obese I group patients show better survival than the normal weight group patients. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | KOREAN ACAD MEDICAL SCIENCES | - |
dc.relation.isPartOf | JOURNAL OF KOREAN MEDICAL SCIENCE | - |
dc.subject | OBESITY | - |
dc.title | The Effect of Body Mass Index on Survival in Advanced Epithelial Ovarian Cancer | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.description.journalClass | 1 | - |
dc.identifier.wosid | 000337339300009 | - |
dc.identifier.doi | 10.3346/jkms.2014.29.6.793 | - |
dc.identifier.bibliographicCitation | JOURNAL OF KOREAN MEDICAL SCIENCE, v.29, no.6, pp.793 - 797 | - |
dc.identifier.kciid | ART001881498 | - |
dc.identifier.scopusid | 2-s2.0-84925221925 | - |
dc.citation.endPage | 797 | - |
dc.citation.startPage | 793 | - |
dc.citation.title | JOURNAL OF KOREAN MEDICAL SCIENCE | - |
dc.citation.volume | 29 | - |
dc.citation.number | 6 | - |
dc.contributor.affiliatedAuthor | Shin, Jin Woo | - |
dc.type.docType | Article | - |
dc.subject.keywordAuthor | Ovarian Neoplasms | - |
dc.subject.keywordAuthor | Survival | - |
dc.subject.keywordAuthor | Body Mass Index | - |
dc.subject.keywordAuthor | Obesity | - |
dc.subject.keywordPlus | OBESITY | - |
dc.relation.journalResearchArea | General & Internal Medicine | - |
dc.relation.journalWebOfScienceCategory | Medicine, General & Internal | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.